
Combined Modality Therapy of Stage IIIC Breast Cancer
2011; Wiley; Volume: 17; Issue: 3 Linguagem: Inglês
10.1111/j.1524-4741.2011.01086.x
ISSN1524-4741
AutoresRodrigo Dienstmann, Luís Guilherme Branco, Lígia M. Rezende, Leila C. Freitas, Carlos Frederico de Freitas Lima, Guilherme J. Rodrigues, Hélio Noronha Filho, Roberta B. Sarmento, I. A. Small, José Bines,
Tópico(s)BRCA gene mutations in cancer
ResumoThe Breast JournalVolume 17, Issue 3 p. 331-333 LETTER TO THE EDITOR Combined Modality Therapy of Stage IIIC Breast Cancer Rodrigo Dienstmann MD, Rodrigo Dienstmann MD Instituto Nacional de Câncer do Brasil, Rio de Janeiro, BrazilSearch for more papers by this authorLuís Guilherme Branco MD, Luís Guilherme Branco MD Instituto Nacional de Câncer do Brasil, Rio de Janeiro, BrazilSearch for more papers by this authorLígia M. Rezende MD, Lígia M. Rezende MD Instituto Nacional de Câncer do Brasil, Rio de Janeiro, BrazilSearch for more papers by this authorLeila C. Freitas MD, Leila C. Freitas MD Instituto Nacional de Câncer do Brasil, Rio de Janeiro, BrazilSearch for more papers by this authorCarlos Frederico Lima MD, Carlos Frederico Lima MD Instituto Nacional de Câncer do Brasil, Rio de Janeiro, BrazilSearch for more papers by this authorGuilherme J. Rodrigues MD, Guilherme J. Rodrigues MD Instituto Nacional de Câncer do Brasil, Rio de Janeiro, BrazilSearch for more papers by this authorHélio Noronha Filho MD, Hélio Noronha Filho MD Instituto Nacional de Câncer do Brasil, Rio de Janeiro, BrazilSearch for more papers by this authorRoberta B. Sarmento MD, Roberta B. Sarmento MD Instituto Nacional de Câncer do Brasil, Rio de Janeiro, BrazilSearch for more papers by this authorIsabele Small MD, Isabele Small MD Instituto Nacional de Câncer do Brasil, Rio de Janeiro, BrazilSearch for more papers by this authorJosé Bines MD, José Bines MD Instituto Nacional de Câncer do Brasil, Rio de Janeiro, BrazilSearch for more papers by this author Rodrigo Dienstmann MD, Rodrigo Dienstmann MD Instituto Nacional de Câncer do Brasil, Rio de Janeiro, BrazilSearch for more papers by this authorLuís Guilherme Branco MD, Luís Guilherme Branco MD Instituto Nacional de Câncer do Brasil, Rio de Janeiro, BrazilSearch for more papers by this authorLígia M. Rezende MD, Lígia M. Rezende MD Instituto Nacional de Câncer do Brasil, Rio de Janeiro, BrazilSearch for more papers by this authorLeila C. Freitas MD, Leila C. Freitas MD Instituto Nacional de Câncer do Brasil, Rio de Janeiro, BrazilSearch for more papers by this authorCarlos Frederico Lima MD, Carlos Frederico Lima MD Instituto Nacional de Câncer do Brasil, Rio de Janeiro, BrazilSearch for more papers by this authorGuilherme J. Rodrigues MD, Guilherme J. Rodrigues MD Instituto Nacional de Câncer do Brasil, Rio de Janeiro, BrazilSearch for more papers by this authorHélio Noronha Filho MD, Hélio Noronha Filho MD Instituto Nacional de Câncer do Brasil, Rio de Janeiro, BrazilSearch for more papers by this authorRoberta B. Sarmento MD, Roberta B. Sarmento MD Instituto Nacional de Câncer do Brasil, Rio de Janeiro, BrazilSearch for more papers by this authorIsabele Small MD, Isabele Small MD Instituto Nacional de Câncer do Brasil, Rio de Janeiro, BrazilSearch for more papers by this authorJosé Bines MD, José Bines MD Instituto Nacional de Câncer do Brasil, Rio de Janeiro, BrazilSearch for more papers by this author First published: 08 April 2011 https://doi.org/10.1111/j.1524-4741.2011.01086.xCitations: 4 Address correspondence and reprint requests to: José Bines, MD, Rua Visconde de Santa Isabel, 274/Terceiro andar, Bairro Vila Isabel, Rio de Janeiro 20560-120, Brazil, or e-mail: [email protected]. Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL References 1 Halsted WS. The results of radical operations for the cure of cancer of the breast. Ann Surg, 1907; 46: 1– 5. 2 Haagnesen CD. Diseases of the Breast. Philadelphia: WB Saunders, 1956. 3 Brito RA, Valero V, Buzdar AU, et al. Long-term results of combined-modality therapy for locally advanced breast cancer with ipsilateral supraclavicular metastases: the University of Texas M.D. Anderson Cancer Center experience. J Clin Oncol, 2001; 19: 628– 33. 4 Pergolizzi S, Settineri N, Santacaterina A, et al. Ipsilateral supraclavicular lymph node metastases from breast cancer as only site of disseminated disease. Chemotherapy alone vs. induction chemotherapy to radical radiation therapy. Ann Oncol, 2001; 12: 1091– 5. 5 Olivotto IA, Chua B, Allan SJ, et al. Long-term survival of patients with supraclavicular metastases of diagnosis of breast cancer. J Clin Oncol, 2003; 21: 851– 4. 6 Beahrs OH, Carr DT, Rubin P (eds). American Joint Committee on Cancer: Manual for Staging of cancer, 5th edn. Philadelphia: Lippincott-Raven, 1997. 7 Singletary SE, Allred C, Ashley P, et al. Revision of the American Joint Committee on Cancer staging system for breast cancer. J Clin Oncol, 2002; 20: 3628– 36. Citing Literature Volume17, Issue3May/June 2011Pages 331-333 ReferencesRelatedInformation
Referência(s)